Second, a few reports [18, 19] have described cases in which EGFR-mutant non-small-cell lung carcinoma has acquired resistance to EGFR-TKI therapy through transformation to small cell lung cancer. This evidence concerns the gene EGFR and small cell lung carcinoma.